Please login to the form below

Not currently logged in
Email:
Password:

Former Roche development head joins Asana advisory board

Dr Kapil Dhingra also brings experience from Lilly

Asana BioSciences Dr Kapil DhingraAsana BioSciences has appointed former head of Roche oncology clinical development Dr Kapil Dhingra to its oncology scientific advisory board.

Dr Dhingra served at Roche from 1999 to 2008, most recently as vice president, head of the Swiss pharma company's oncology disease biology leadership team and head of oncology clinical development.

Prior to that he worked at Lilly as a clinical research physician having previously served at the faculty of M.D. Anderson Cancer Center in Houston, Texas, where he pursued laboratory and clinical cancer research.

Dr Sandeep Gupta, founder, president and CEO of New Jersey-based Asana Biosciences, said: “We welcome Dr. Dhingra to our oncology scientific advisory board. His expertise, proven track record and strategic insights will be great assets to Asana.

I look forward to working closely with him and other SAB members in advancing our robust and differentiated oncology pipeline further into clinical development.”

The founder of KAPital Consulting, Dr Dhingra currently serves on the boards of Exosome Diagnostics as chairman of the board, Advanced Accelerator Applications, Five Prime and Autolus.

11th January 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics